A PEGylated fibroblast growth factor 21 variant improves hepatic steatosis in a mouse model of non-alcoholic steatohepatitis, as determined by magnetic resonance imaging-derived hepatic fat-fraction
2005 ◽
Vol 14
(5)
◽
pp. 187-192
2002 ◽
Vol 74
(2)
◽
pp. 481-487
◽
2019 ◽
Vol 65
(6)
◽
pp. 515-525
◽
Keyword(s):
2017 ◽
Vol 13
(9)
◽
pp. 1515-1523
◽
Keyword(s):
2016 ◽
Vol 101
(1)
◽
pp. 191-198
◽
Keyword(s):
2012 ◽
Vol 37
(6)
◽
pp. 1359-1370
◽
Keyword(s):